This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Hippotherapy to Improve the Balance of Children With Movement Disorders (HPOT)

This study has been completed.
Information provided by:
Central Michigan University Identifier:
First received: March 9, 2011
Last updated: March 10, 2011
Last verified: March 2011
The purpose of this study is to determine if adding hippotherapy treatment will improve balance for children ages 5-17 who have disabilities such as cerebral palsy and down syndrome. We also want to find out if by improving their balance the children increase their participation in age appropriate activities.

Condition Intervention
Neuromuscular Diseases Cerebral Palsy Down Syndrome Autism Developmental Coordination Disorder Other: Hippotherapy

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Hippotherapy to Improve Balance Deficits in a Cohort of Children With Movement Disorders: A Pilot Study

Resource links provided by NLM:

Further study details as provided by Central Michigan University:

Primary Outcome Measures:
  • Pediatric Balance Scale [ Time Frame: 8-9 weeks ]
    The Pediatric Balance Scale (PBS) is a standardized 14 item test of various component activities related to balance. It is a modified child version of the adult Berg Balance Scale. The PBS has high total score test-retest reliability of ICC (3,1) =0.998, as well as good interrater reliability (ICC(3,1) = 0.997).1

Secondary Outcome Measures:
  • Activities Scale for Kids [ Time Frame: 8-9 weeks ]
    Activities Scale for Kids - Participation (ASKp) is a self-administered 30 item questionaire that measures the impact of children's disability to overall function and participation within relevant environments. It correlates well with parent reports on the Childhood Health Assessment Questionnaire (r=0.81, p<0.000) and clinician observations of children's function (ICC=0.92, p<0.000).

Enrollment: 16
Study Start Date: September 2006
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment group
Children between 5-17 years who have balance deficits related to any movement disorder (preferably neuromuscular)
Other: Hippotherapy
Children will receive treatment by a licensed physical therapist using hippotherapy as the treatment strategy. This includes sitting on a horse who's movement is controlled by a horse leader, with the PT directing the movements required of the horse, as well as supplying supplemental cues to the participant. Alternative positions (such as sitting backward and sideways) may also be used during the treatment session.

Detailed Description:
The primary purpose of this study is to determine the effects of hippotherapy on the balance of children with developmental disorders that cause mild to moderate balance problems. The secondary purpose is to determine if the use of hippotherapy also improves perceived functional abilities and thus quality of life as measured by the pediatric balance scale and Activities Scale for Kids (respectively)

Ages Eligible for Study:   5 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • between the ages of 5 and 17
  • have a neuromuscular diagnosis or confirmed difficulties with balance
  • be able to stand 4 seconds without an assistive device
  • be able to follow testing instructions
  • must be under 250 pounds
  • be able to attend a minimum 10/12 sessions.

Exclusion Criteria:

  • any compounding orthopedic or medical condition not related to the primary developmental diagnosis.
  • previous hippotherapy intervention or therapeutic riding experience
  • allergies or aversion to horses.
  • refusal of parents to sign the therapeutic riding center's liability release form
  • any new treatments (includes therapies, drugs, or other complementary treatments) within one month of the start of the study or plans for new treatments during the intervention period
  • lack of a physician referral for physical therapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01313325

United States, Michigan
CHUM Therapeutic Riding Center
Dansville, Michigan, United States, 48854
Sponsors and Collaborators
Central Michigan University
Principal Investigator: Debbie J Silkwood-Sherer, PT, DHS Central Michigan University
  More Information

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Dr. Debbie Silkwood-Sherer, Central Michigan University Identifier: NCT01313325     History of Changes
Other Study ID Numbers: 09/14/2006
Study First Received: March 9, 2011
Last Updated: March 10, 2011

Keywords provided by Central Michigan University:
neuromuscular disorders
balance deficits

Additional relevant MeSH terms:
Cerebral Palsy
Down Syndrome
Movement Disorders
Neuromuscular Diseases
Motor Skills Disorders
Pathologic Processes
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Intellectual Disability
Neurobehavioral Manifestations
Neurologic Manifestations
Abnormalities, Multiple
Congenital Abnormalities
Chromosome Disorders
Genetic Diseases, Inborn
Neurodevelopmental Disorders
Mental Disorders processed this record on August 17, 2017